|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Allocating and distributing organs, 95 access to immunosuppressive medications following transplantation, 95 equitable access to transplantation, 95 Allosensitization, 59 Altruism, cultural norms and models of willingness to donate, 70–71 AMA. See American Medical Association American Board for Transplant Certification (ABTC), 99 American Heart Association (AHA), 153–154, 156 American Medical Association (AMA), 197, 214, 225, 250, 257 American Nurses Association, 197 American Society of Transplant Physicians (ASTP), 133 American Society of Transplant Surgeons (ASTS), 33, 188, 249, 252 American Society of Transplantation (AST), 33, 188 AOPO. See Association of Organ Procurement Organizations Appeals. See Acceptable appeals Arguments for and against preferred-access approaches, 254–258 the adverse selection problem, 256–257 the information problem, 256 the unfair allocation problem, 257–258 Arkansas, 194 Asian-Pacific Islanders, 195 Assessment of DCDD strategies in the United States, 141–143 DCDD cases reported by OPOs, 143 deceased donors, 142 organs recovered from DCDD donors in the U.S., 143 Assessment of presumed-consent policies, 212–224 autonomy-based arguments, 218–219 chances of a presumed-consent policy being adopted in the U.S., 222–224 cost-effectiveness, 216 effectiveness in increasing the number of transplantable organs, 212–216 individual generosity, societal generosity, and mutual self-interest, 221–222 possible benefits of and barriers to presumed-consent policies, 223 reducing the burden of familial decision making, 216–218 Association of Organ Procurement Organizations (AOPO), 5, 21, 33, 97, 99, 119, 136 AST. See American Society of Transplantation ASTP. See American Society of Transplant Physicians ASTS. See American Society of Transplant Surgeons Austria, 27 Autonomy-based arguments, 218–219 B Barriers, to a futures market, 234–235 Behavioral interventions, 300–301 Brain function, controversy over, 146 Breakthrough collaborative model, 103. See also Organ Donation Breakthrough Collaboratives; Organ Transplantation Breakthrough Collaborative; Transplantation breakthrough collaboratives British Medical Association, 222n Buying and selling of organs, 239–242 advantages of the gift model, 240–241 claims of a liberty right to sell organs, 241–242 C California Transplant Donor Network, 109 Candidates on the transplant waiting list, growth in numbers of, 2, 16 Cardiac arrests, 138, 286–287, 308 Cardiac life-support efforts, criteria for termination of advanced, 132 CDC. See Centers for Disease Control and Prevention CDD. See Circulatory determination of death Centers for Disease Control and Prevention (CDC), 8, 198–199
|
|
|||||||||||||||
